Robbins Geller Obtains Preliminary Approval of $400 million Securities Class Action Settlement Against Pfizer Inc.
On March 16, 2015, the Court entered an order granting preliminary approval to the $400 million settlement obtained by Robbins Geller on the eve of trial against Pfizer.
The final approval hearing is currently scheduled for July 30, 2015 at 2:30 p.m. at the U.S. District Court for the Southern District of New York, 500 Pearl Street, Courtroom 14D, New York, New York 10007. Additional information about the settlement, case documents, and deadlines associated with the settlement can be found at http://www.pfizersecuritiessettlement.com/
Read More Firm News
- July 30, 2021
- Paul Geller and Leadership Committee Honored as “Litigators of the Week” Upon Announcement of Historic $26 Billion Settlement in Opioid LitigationJuly 23, 2021
- June 22, 2021
- Robbins Geller Obtains Ninth Circuit Decision Vacating District Court’s Judgment Dismissing Complaint Against Google and AlphabetJune 16, 2021
- June 7, 2021